Pseudomonas aeruginosa infection destroys the barrier function of lung epithelium and enhances polyplex-mediated transfection

Human Gene Therapy

Volumn 18, Issue 7, 2007, Pages 642-652

  Rejman, Joanna ^a   Di Gioia, Sante ^a   Bragonzi, Alessandra ^a   Conese, Massimo ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PLASMID DNA; POLYETHYLENEIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; CYSTIC FIBROSIS; ESCHERICHIA COLI; GENETIC TRANSFECTION; GRAM NEGATIVE INFECTION; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; TIGHT JUNCTION;

ANIMALS; CELLS, CULTURED; ESCHERICHIA COLI INFECTIONS; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, INBRED C57BL; PLASMIDS; POLYETHYLENEIMINE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; TIGHT JUNCTIONS; TRANSFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; PSEUDOMONAS AERUGINOSA;

EID: 34547538332     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.192     Document Type: Article

References (46)

1. ANDERSON, J.M., and VAN ITALLIE, C.M. (1995). Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269, G467-G475.
2. ARTURSSON, P., and MAGNUSSON, C. (1990). Epithelial transport of drugs in cell culture. II. Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 79, 595-600.
3. AZGHANI, A.O. (1996). Pseudomonas aeruginosa and epithelial permeability: Role of virulence factors elastase and exotoxin A. Am. J. Respir. Cell Mol. Biol. 15, 132-140.
4. AZGHANI, A.O., GRAY, L.D., and JOHNSON, A.R. (1993). A bacterial protease perturbs the paracellular barrier function of transporting epithelial monolayers in culture. Infect. Immun. 61, 2681-2686.
5. BHAT, M., TOLEDO-VELASQUEZ, D., WANG, L., MALANGA, C.J., MA, J.K., and ROJANASAKUL, Y. (1993). Regulation of tight junction permeability by calcium mediators and cell cytoskeleton in rabbit tracheal epithelium. Pharm. Res. 10, 991-997.
6. BOLES, B.R., THOENDEL, M., and SINGH, P.K. (2005). Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol. Microbiol. 57, 1210-1223.
7. BRAGONZI, A., and CONESE, M. (2002). Non-viral approach toward gene therapy of cystic fibrosis lung disease. Curr. Gene Ther. 2, 295-305.
8. BRAGONZI, A., DINA, G., VILLA, A., CALORI, G., BIFFI, A., BORDIGNON, C., ASSAEL, B.M., and CONESE, M. (2000). Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther. 7, 1753-1760.
9. BRAGONZI, A., COPRENI, E., DE BENTZMANN, S., ULRICH, M., and CONESE, M. (2004). Airway epithelial cell-pathogen interactions. J. Cyst. Fibres. 3(Suppl. 2), 197-201.
10. BURNS, J.L., GIBSON, R.L., McNAMARA, S., YIM, D., ROSENFELD, M., HIATT, P., McCOY, K., CASTILE, R., SMITH, A.L., and RAMSEY, B.W. (2001). Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183, 444-452.
11. CATERSON, A.J., HORNER ZU BENTRUP, K., OTT, C.M., CLARKE, M.S., PIERSON, D.L., VANDERBURG, C.R., BUCHANAN, K.L., NICKERSON, C.A., and SCHURR, M.J. (2005). A549 lung epithelial cells grown as three-dimensional aggregates: Alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect. Immun. 73, 1129-1140.
12. CHI, E., MEHL, T., NUNN, D., and LORY, S. (1991). Interaction of Pseudomonas aeruginosa with A549 pneumocyte cell. Infect. Immun. 59, 822-828.
13. CHU, Q., TOUSIGNANT, J.D., FANG, S., JIANG, C., CHEN, L.H., CHENG, S.H., SCHEULE, R.K., and EASTMAN, S.J. (1999). Binding and uptake of cationic lipid:pDNA complexes by polarized airway epithelial cells. Hum. Gene Ther. 10, 25-36.
14. 2-adrenergic receptor agonist. Am. J. Respir. Cell Mol. Biol. 30, 605-612.
15. COYNE, B.C., KELLY, M.M., BOUCHER, R.C., and JOHNSON, L.G. (2000). Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am. J. Respir. Cell Mol. Biol. 23, 602-609.
16. COZENS, A.L., YEZZI, M.J., KUNZELMANN, K., OHRUI, T., CHIN, L., ENG, K., FINKBEINER, W.E., WIDDICOMBE, J.H., and GRUENERT, D.C. (1994). CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10, 38-47.
17. DACHEUX, D., ATTREE, I., and TOUSSAINT, B. (2001). Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates. Infect. Immun. 69, 538-542.
18. DENKER, B.M., and NIGAM, S.K. (1998). Molecular structure and assembly of the tight junction. Am. J. Physiol. 274, F1-F9.
19. FLEISZIG, S.M., ZAIDI, T.S., PRESTON, M.J., GROUT, M., EVANS, D.J., and PIER, G.B. (1996). Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect. Immun. 64, 2288-2294.
20. FLEISZIG, S.M., EVANS, D.J., DO, N., VALLAS, V., SHIN, S., and MOSTOV, K.E. (1997). Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 66, 43-51.
21. FORBES, B. (2000). Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharm. Sci. Technol. Today 3, 18-27.
22. FORBES, B., SHAH, A., MARTIN, G.P., and LANSLEY, A.B. (2003). The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport. Int. J. Pharm. 257, 161-167.
23. GREGORY, L.G., HARBOTTLE, R.P., LAWRENCE, L., KNAPTON, H.J., THEMIS, M., and COUTELLE, C. (2003). Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo. Mol. Ther. 7, 19-26.
24. GRIESENBACH, U., GEDDES, D.M., and ALTON, E.W. (2004). Advances in cystic fibrosis gene therapy. Curr. Opin. Pulm. Med. 10, 542-546.
25. GRIESENBACH, U., GEDDES, D.M., and ALTON, E.W. (2006). Gene therapy progress and prospects: Cystic fibrosis. Gene Ther. 13, 1061-1067.
26. GUMBINER, B.M. (1993). Breaking through the tight junction barrier. J. Cell Biol. 123, 1631-1633.
27. JOHNSON, L., OLSEN, J., SARKADI, B., MOORE, K., SWANSTROM, R., and BOUCHER, R. (1992). Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2, 21-25.
28. JOHNSON, L.G., VANHOOK, M.K., COYNE, C.B., HAYKAL-COATES, N., and GAVETT, S.H. (2003). Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo. Hum. Gene Ther. 14, 729-747.
29. KAZMIERCZAK, B.I., JOU, T.S., MOSTOV, K., and ENGEL, J.N. (2001). Rho GTPase activity modulates Pseudomonas aeruginosa internalization by epithelial cells. Cell. Microbiol. 3, 85-98.
30. LAU, G.W., HASSETT, D.J., and BRITIGAN, B.E. (2005). Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol. 13, 389-397.
31. LEE, A., CHOW, D., HAUS, B., TSENG, W., EVANS, D., FLEISZIG, S., CHANDY, G., and MACHEN, T. (1999). Airway epithelial tight junctions and binding and cytotoxicity of Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 21, L204-L217.
32. MAN, Y., HART, V.J., RING, C.J.A., SANJAR, S., and WEST, M.R. (2000). Loss of epithelial integrity resulting from E-cadherin dysfunction predisposes airway epithelial cells to adenoviral infection. Am. J. Respir. Cell Mol. Biol. 23, 610-617.
33. MARTINEZ-PALOMO, A., MEZA, I., BEATY, G., and CEREIJIDO, M. (1980). Experimental modulation of occluding junctions in a cultured transporting epithelium. J. Cell Biol. 87, 736-745.
34. MATHIAS, N.R., YAMASHITA, F., and LEE, V.H.L. (1996). Respiratory epithelial cell culture models for evolution of ion and drug transport. Adv. Drug Deliv. Rev. 22, 215-246.
35. PLOTKOWSKI, M.C., DE BENTZMANN, S., PEREIRA, S.H.M., ZAHM, J.-M., BAJOLET-LAUDINAT, O., ROGER, P., and PUCHELLE, E. (1999). Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity. Am. J. Respir. Cell Mol. Biol. 20, 880-890.
36. RAJAN, S., CACALANO, G., BRYAN, R., RATNER, A.J., SONTICH, C.U., VAN HEECKEREN, A., DAVIS, P., and PRINCE, A. (2000). Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: Analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am. J. Respir. Cell Mol. Biol. 23, 304-312.
37. RAMALHO, A.S., BECK, S., MEYER, M., PENQUE, D., CUTTING, G.R., and AMARAL, M.D. (2002). Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 5, 619-627.
38. RATJEN, F., and DORING, G. (2003). Cystic fibrosis. Lancet 361, 681-689.
39. ROMLING, U., FIEDLER, B., BOSSHAMMER, J., GROUTHES, D., GREIPEL, J., VON DER HARDT, H., and TUMMLER, B. (1994). Epidemiology of chronic Pseudomonas aeruginosa infection in cystic fibrosis. J. Infect. Dis. 170, 1616-1621.
40. SINGH, P.K., SCHAEFER, A.L., PARSEK, M.R., MONINGER, T.O., WELSH, M.J., and GREENBERG, E.P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762-764.
41. STOODLEY, P., SAUER, K., DAVIES, D.G., and COSTERTON, J.W. (2002). Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56, 187-209.
42. STOVER, C.K., PHAM, X.Q., ERWIN, A.L., MIZOGUCHI, S.D., WARRENER, P., HICKEY, M.J., BRINKMAN, F.S., HUFNAGLE, W.O., KOWALIK, D.J., LAGROU, M., GARBER, R.L., GOLTRY, L., TOLENTINO, E., WESTBROCK-WADMAN, S., YUAN, Y., BRODY, L.L., COULTER, S.N., FOLGER, K.R., KAS, A., LARBIG, K., LIM, R., SMITH, K., SPENCER, D., WONG, G.K., WU, Z., PAULSEN, I.T., REIZER, J., SAIER, M.H., HANCOCK, R.E., LORY, S., and OLSON, M.V. (2000). Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959-964.
43. TUMMLER, B. (2006). Clonal variations in Pseudomonas aeruginosa. In: Pseudomonas. J.L. Ramos and R.C. Levesque, eds. (Springer-Verlag, New York) pp. 35-68.
44. VANDEVANTER, D.R., and VAN DALFSEN, J.M. (2005). How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis? Pediatr. Pulmonol. 39, 504-506.
45. WAN, H., WINTON, H.L., SOELLER, C., STEWART, G.A., THOMPSON, P.J., GRUENERT, D.C., CANNELL, M.B., GARROD, D.R., and ROBINSON, C. (2000). Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-. Eur. Respir. J. 15, 1058-1068.
46. ZULIANELLO, L., CONRAD, C., KOLER, T., CAILLE, D., LACROIX, J.-S., and MEDA, P. (2006). Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect. Immun. 74, 3134-3147.